Navigation Links
CorVel Corporation Announces Earnings Release Webcast
Date:7/17/2008

IRVINE, Calif., July 17 /PRNewswire-FirstCall/ -- In conjunction with CorVel Corporation's (Nasdaq: CRVL) quarterly earnings release, CorVel will be conducting a conference call that will be broadcast live over the Internet on Tuesday, August 5th at 11:30 am Eastern Time.

Event: CorVel Corporation Quarterly Earnings Release

Hosted by: Dan Starck, President and CEO

Gordon Clemons, Chairman

Date: 11:30 am Eastern Time, Tuesday, August 5th, 2008

Login: http://www.corvel.com

Contact: CorVel's Investor Relations Department, 1-949-851-1473

About CorVel

CorVel Corporation is a national provider of leading-edge services and solutions in the field of disability management. CorVel specializes in applying information technology and e-commerce applications to improve outcomes in the workers' compensation, group health, auto and disability management insurance markets. The Company provides claims management solutions in addition to networks of preferred providers, case management, utilization management and medical bill review to more than 2,000 clients nationwide. Leveraging its commitment to flexibility and personal service, CorVel delivers custom solutions for employers, insurers, third party administrators and government entities.

This press release contains forward-looking statements that are subject to risks and uncertainties, including the risk that the historical financial performance of the Company may not be indicative of future financial performance and the risk that the recent performance of the Company's Common Stock may not be indicative of its future performance, as well as other risks de
'/>"/>

SOURCE CorVel Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. CorVel Corporation Announces Earnings Release Webcast
2. CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care
3. Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases
4. Webcast Alert: Neogen Corporation Announces Year-End Results
5. PURE Bioscience Announces Distribution Agreement With Orchem Corporation
6. Sigma-Aldrich Corporations 2nd Quarter 2008 Earnings Conference Call
7. Genaera Corporation Elects Paul K. Wotton to Board of Directors
8. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
9. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
10. FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008
11. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , AMSTERDAM, November 30 /P...ing publisher of scientific, medical and technical...-launch of Embase, its comprehensive biomedical,da... from more than 7,000,active, peer reviewed journa...n the advancement of new biomedical,and pharmaceut...
(Date:11/27/2009)... A mechanised blue dye test alternative ... quality assurance one step closer for pharma-comp...testing machine developed by Sepha for use with...n several local and global pharma-companies such a...ty assurance and productivity improvements on the ...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 25 /P... painful year. Not so for BodyLogicMD. The nation...hysicians specializing exclusively in medically su...mber of physicians in its network since Nove...progress to add more physician-owned centers, incl...
(Date:11/24/2009)...is available in German . , Whether it,s CD ...D tags (Radio Frequency Identification) are increa...make it possible to label objects or goods and ide...ppropriate scanner can read and process the data c... to goods under production conditions of up to 100...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Intelligence inside metal components 2
...armaceuticals, Inc., a development-stage pharmaceu... interference (RNAi)-based therapeutics, today ann...ientific Officer, presented a study titled, "PF-04...801, Penetrates Retinal Cells Producing Target Gen...Association for Research in Vision and Ophthalmolo...
...erapeutics, Inc. (Nasdaq: OREX ), a biopharmaceu... today announced that Jay Hagan has joined the org...velopment and Strategy. , , "Jay brings over 15...elopment experience in a variety of roles includin...transactions. We are excited to add someone of Ja...
...tfolio of Regenerative Treatments , , NEW YORK, M...s pioneering the pre-disease collection, processin...ture medical need, announced today it has signed a...the Asia territory to use an innovative process th...to treat a variety of musculoskeletal diseases. ,...
Other Biology Technology:Quark Pharmaceuticals Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3 2Quark Pharmaceuticals Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3 3Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 2Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 3Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 4NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases 2NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases 3NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases 4
(Date:11/30/2009)...g your extended family over the holidays was slowl...e December 2009 print issue of the Journal of Leu...that you might be right. Here,s the good news: res...w treatments that help keep autoimmune diseases li...t,s because researchers from the University of Con...
(Date:11/26/2009)...d deer have been caught in the hunters, sights for...han decorative. They are lethal weapons that stags...he University of York, UK, has been intrigued by t...entury and has become fascinated by the mechanical...aboration with Tomas Landete-Castillejos at the Un...
(Date:11/26/2009)...ccus Aureus ) and other drug-resistant bacteria co...ototype devices have been developed to offer safe,... , Two prototype devices have been developed: on... hands and feet) in hospitals and public spaces wh... to shoot bacteria-killing agents into infested ch...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 1Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 2Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 1Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 2Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 1Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 2
... biologists at the University of California, San D...makes them susceptible to Bacillus thuringiensis t...a and widely used by organic farmers and in geneti..., Their findings should facilitate the design and ...earchers believe also possess the molecule, from d...
...ere have used a new microscopic, three-dimensional... themselves into fat cells, and then to function i.... , While other studies have previously grown fat ...ls never completely functioned in the same way the...genetic and biologic components that all cells req...
...isite trial designed to examine the safety and pre...crobicides to prevent HIV infection has opened to ...National Institute of Allergy and Infectious Disea...alth, represents a partnership among various resea..., Although no licensed microbicides are available ...
Other Biology News:UCSD discovery may help extend life of natural pesticide 2UCSD discovery may help extend life of natural pesticide 3Tiny scaffolding allows stem cells to become working fat cells 2Tiny scaffolding allows stem cells to become working fat cells 3 MetaChip provides quick, efficient toxicity screening of potential drugs 2
...is the first higher plant to be fully sequenced an...ism for gene expression research in higher plants....e ATH1 v.5 database of The Institute for Genomic R...ase at the University of Delaware. Nearly 40,000 f...
...that is designed for use with HRP conjugated rabbi... with a mouse monoclonal coating antibody. &bull...prevent non-specific binding between the coating a...y be used to stabilize newly conjugated antibodies...
Expand High Fidelity PCR System, dNTPack (Not available in US) from Roche Applied Science
Factor Xa Protease from QIAGEN
Biology Products: